Japan Medical Dynamic Marketing, Inc. (JP:7600)
:7600
Want to see JP:7600 full AI Analyst Report?
7600 Stock Chart & Stats
¥487.00
-¥2.00(-0.33%)
At close: 4:00 PM EST
¥487.00
-¥2.00(-0.33%)
Day’s Range― - ―
52-Week Range¥445.00 - ¥786.00
Previous CloseN/A
Volume41.50K
Average Volume (3M)89.74K
Market Cap
¥18.67B
Enterprise Value¥21.58B
Total Cash (Recent Filing)¥2.35B
Total Debt (Recent Filing)¥4.31B
Price to Earnings (P/E)53.8
Beta0.54
Next Earnings
Jul 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.12%
Share Statistics
EPS (TTM)-25.42
Shares Outstanding26,475,880
10 Day Avg. Volume96,020
30 Day Avg. Volume89,743
Financial Highlights & Ratios
PEG Ratio-0.34
Price to Book (P/B)0.56
Price to Sales (P/S)0.59
P/FCF Ratio-8.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)18.2
Revenue Forecast (FY)¥25.30B
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthA large equity base and moderate leverage (debt/equity ~0.23 in 2026) provide financial flexibility and downside resilience. This supports funding of working capital, targeted capex or M&A without immediate refinancing stress, preserving strategic optionality over months.
Return To ProfitabilityRecovering to positive earnings in 2026 and maintaining healthy gross margins signals operational resilience and product-level margin strength. If maintained, this supports longer-term margin recovery and cash generation as revenue stabilizes and cost controls persist.
Defensive Industry ExposurePositioning in medical devices gives exposure to structurally steady healthcare demand and longer product lifecycles. Such industry characteristics typically support more predictable revenue streams and resilience to economic cycles over a multi-month horizon.
Bears Say
Revenue DecelerationA shift from multi-year growth to a YoY revenue decline undermines scale advantages and raises the risk that fixed costs will pressure margins. Continued top-line weakness limits reinvestment capability and makes sustainable margin recovery more difficult over the medium term.
Weak Cash GenerationDeeply negative free cash flow and sharply lower operating cash flow constrain internal funding for operations and capex. Prolonged cash deficits increase reliance on external financing, which can dilute flexibility and raise execution risk for multi-month strategic initiatives.
Margin CompressionSevere margin compression to very low operating and net margins reduces the company's earnings cushion and lowers ROE. Persistently thin margins limit the ability to self-fund growth, raise vulnerability to cost shocks, and slow long-term value compounding.
Japan Medical Dynamic Marketing, Inc. News
7600 FAQ
What was Japan Medical Dynamic Marketing, Inc.’s price range in the past 12 months?
Japan Medical Dynamic Marketing, Inc. lowest stock price was ¥445.00 and its highest was ¥786.00 in the past 12 months.
What is Japan Medical Dynamic Marketing, Inc.’s market cap?
Japan Medical Dynamic Marketing, Inc.’s market cap is ¥18.67B.
When is Japan Medical Dynamic Marketing, Inc.’s upcoming earnings report date?
Japan Medical Dynamic Marketing, Inc.’s upcoming earnings report date is Jul 24, 2026 which is in 64 days.
How were Japan Medical Dynamic Marketing, Inc.’s earnings last quarter?
Japan Medical Dynamic Marketing, Inc. released its earnings results on Apr 30, 2026. The company reported -¥0.91 earnings per share for the quarter, missing the consensus estimate of N/A by -¥0.91.
Is Japan Medical Dynamic Marketing, Inc. overvalued?
According to Wall Street analysts Japan Medical Dynamic Marketing, Inc.’s price is currently Overvalued.
Does Japan Medical Dynamic Marketing, Inc. pay dividends?
Japan Medical Dynamic Marketing, Inc. pays a Annually dividend of ¥15 which represents an annual dividend yield of 3.12%. See more information on Japan Medical Dynamic Marketing, Inc. dividends here
What is Japan Medical Dynamic Marketing, Inc.’s EPS estimate?
Japan Medical Dynamic Marketing, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Japan Medical Dynamic Marketing, Inc. have?
Japan Medical Dynamic Marketing, Inc. has 26,475,880 shares outstanding.
What happened to Japan Medical Dynamic Marketing, Inc.’s price movement after its last earnings report?
Japan Medical Dynamic Marketing, Inc. reported an EPS of -¥0.91 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 9.344%.
Which hedge fund is a major shareholder of Japan Medical Dynamic Marketing, Inc.?
Currently, no hedge funds are holding shares in JP:7600
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Japan Medical Dynamic Marketing, Inc.
Japan Medical Dynamic Marketing, INC. develops, manufactures, imports, and sells medical devices in Japan and the United States. The company provides trauma devices, including nails, screws, plates, and other products surgically implanted in the fracture site; joint prostheses, which replaces natural joints and restores functions damaged or lost due to disease or injury; spinal fixation devices for the use in spinal instability surgery; and artificial bone fillers for the treatment of bone fractures, tumors, and other defects. It offers its products to medical professionals and hospitals. The company was incorporated in 1973 and is headquartered in Tokyo, Japan.
Technical Analysis
CYBERDYNE
―
PHC Holdings Corp.
―
Eiken Chemical Co., Ltd.
―
Techno Medica Co., Ltd.
―
Nihon Kohden Corporation
―
Options Prices
Currently, No data available
---